#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	26552	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2051	1277.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1723	1723	T	1456	T,C	1369,5	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	26552	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2051	1277.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1457	1457	C	1464	C,T	1399,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49870	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3513	1403.6	0	.	n	.	0	T695C	SNP	695	695	T	1025	1025	C	1567	C,T	1493,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49870	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3513	1403.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1667	1667	A	1601	A,G	1517,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49870	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3513	1403.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2301	2301	C	1522	C,A	1430,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49870	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3513	1403.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2375	2375	A	1536	A	1463	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	49870	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3513	1403.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2927	2927	C	1503	C	1441	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	3324	folP	855	855	100.0	folP.l6.c4.ctg.1	1625	202.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1101	1103	AGC	321;318;318	A,G;G;C	305,1;304;299	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	8946	gyrA	2751	2751	99.93	gyrA.l15.c4.ctg.1	3356	263.3	0	.	p	.	0	G95A	NONSYN	283	285	GGC	603	605	GCC	282;284;288	G,C;C,G;C	267,1;271,1;273	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	8946	gyrA	2751	2751	99.93	gyrA.l15.c4.ctg.1	3356	263.3	1	SNP	p	S91F	1	.	.	271	273	TTC	591	593	TTC	277;275;278	T;T;C	263;261;258	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	2910	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1291	222.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	419	421	ACC	333;333;328	A,G,C;C;C	305,1,1;311;308	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	2910	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1291	222.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	617	619	CAC	346;350;355	C;A;C	334;330;341	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	2910	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1291	222.9	0	.	p	.	0	L114fs	FSHIFT	340	340	T	643	643	T	343	T	324	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	2910	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1291	222.9	1	SNP	p	G45D	0	.	.	133	135	GGC	437	439	GGC	333;335;336	G;G;C	314;314;316	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1700	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	815	204.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1373	1375	GTC	371;371;371	G,A;T,G;C,T	341,1;332,1;342,1	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	1	SNP	p	D86N	0	.	.	256	258	GAC	479	481	GAC	310;308;312	G;A;C	295;287;296	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	1	SNP	p	R87W	0	.	.	259	261	CGT	482	484	CGT	314;314;314	C;G;T	300;300;296	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	1	SNP	p	S87R	1	.	.	259	261	CGT	482	484	CGT	314;314;314	C;G;T	300;300;296	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	1	SNP	p	R87I	0	.	.	259	261	CGT	482	484	CGT	314;314;314	C;G;T	300;300;296	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	8456	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2799	297.7	1	SNP	p	S88P	0	.	.	262	264	TCC	485	487	TCC	313;314;310	T;C,G;C	297;299,1;300	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	7314	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2454	293.9	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1617	1619	TCC	381;382;381	T,C;C;C	350,1;355;355	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	7314	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2454	293.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1479	1481	GGC	353;348;347	G,A;G;C,A	340,1;335;329,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1339	1341	GCA	407;407;414	G;C;A	383;379;391	penA.18.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1342	1344	ATC	415;414;415	A;T;C	386;388;389	penA.18.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1354	1356	GTG	423;421;425	G;T;G,C	402;396;405,1	penA.18.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1354	1356	GTG	423;421;425	G;T;G,C	402;396;405,1	penA.18.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1858	1860	ACC	344;343;347	A;C;C,G	313;323;323,1	penA.18.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1912	1914	ACG	313;315;313	A;C;G	255;270;269	penA.18.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1912	1914	ACG	313;315;313	A;C;G	255;270;269	penA.18.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2035	2037	AGC	304;299;303	A,G;G;C,T	289,1;289;282,1	penA.18.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2044	2046	GGC	295;295;293	G;G;C	275;274;272	penA.18.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	6912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	279.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2062	2064	CCG	225;229;223	C,G;C,G;G,C	181,12;188,4;190,1	penA.18.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	10336	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3166	322.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1633	1635	CCG	388;391;394	C,A;C;G,C	355,2;364;358,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4386	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1647	262.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	334	C	303	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	A251V	NONSYN	751	753	GCG	55	57	GTA	57;57;57	G;T;A	52;51;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	115	117	ACT	57;55;50	A;C;T	52;51;46	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	Y273N	NONSYN	817	819	TAT	121	123	AAT	31;28;22	A;A;T	27;24;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	124	126	AGT	22;22;22	A;G;T	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	133	135	CAC	22;22;22	C;A;C	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	223	225	GAA	14;14;14	G;A;A	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	235	237	GCA	14;14;14	G;C;A,G	14;14;13,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	238	240	GAC	13;13;13	G;A;C	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	244	246	ATC	13;13;13	A;T;C	13;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	250	252	TCG	11;11;11	T;C;G	11;11;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	256	258	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	259	261	AGC	9;9;10	A;G;C	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	262	264	GCC	8;8;8	G;C;C	8;8;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	458	porB1a	984	271	90.77	porB1a.l15.c30.ctg.2	320	30.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	268	270	GTT	8;8;8	G;T;T	8;8;8	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	459	461	GGA	393;397;407	G;G;A	377;379;389	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	576	578	GCT	399;401;401	G,A;C,T;T,G	375,1;384,1;377,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	582	584	AGC	399;396;398	A;G;C,T	377;379;374,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	744	746	CAA	436;428;426	C,G;A;A	415,1;410;408	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	768	770	GCA	428;425;426	G;C;A	404;401;395	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	876	878	CAA	421;411;412	C;A,G,C;A	392;386,1,1;388	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	N189S	NONSYN	565	567	AAC	882	884	AGC	423;425;428	A;G,A;C	397;397,1;399	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	951	951	T	443	T	414	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	1	SNP	p	G120K	1	.	.	358	360	AAG	675	677	AAG	410;412;413	A;A,C;G	400;402,1;403	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	1	SNP	p	A121D	1	.	.	361	363	GAC	678	680	GAC	415;413;414	G;A;C	407;399;401	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	5290	porB1b	1041	1041	98.18	porB1b.l15.c4.ctg.1	1575	332.9	1	SNP	p	D121N	0	.	.	361	363	GAC	678	680	GAC	415;413;414	G;A;C	407;399;401	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	17682	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4729	369.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	2060	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1131	180.5	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	425;423;422	A;T;G	410;408;406	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
